Endothelial dysfunction

Résumé

In vascular diseases, endothelial dysfunction is a systemic pathological state of the endothelium. Along with acting as a semi-permeable membrane, the endothelium is responsible for maintaining vascular tone and regulating oxidative stress by releasing mediators, such as nitric oxide, prostacyclin and endothelin, and controlling local angiotensin-II activity. Research Atherosclerosis Endothelial dysfunction may be involved in the development of atherosclerosis and may predate vascular pathology. Endothelial dysfunction can also lead to increased adherence of monocytes and macrophages, as well as promoting infiltration of LDL in the vessel wall. Dyslipidemia and hypertension are well known to contribute to endothelial dysfunction, and lowering blood pressure and LDL has been shown to improve endothelial function, particularly when lowered with ACE inhibitors, calcium channel blockers, and statins. Nitric oxide Nitric oxide (NO) suppresses p

Source officielle

https://en.wikipedia.org/wiki/Endothelial_dysfunction

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Publications associées (17)

Publications associées

Chargement

Personnes associées (5)

Personnes associées

Chargement

Unités associées (1)

Unités associées

Chargement

Concepts associés (7)

Concepts associés

Chargement

Cours associés (3)

Cours associés

Chargement

Séances de cours associées (3)

Séances de cours associées

Chargement

Considerations for analysis of endothelial shear stress and strain in FSI models of atherosclerosis

Lydia Aslanidou, Fotios Savvopoulos

Atherosclerosis is a lipid driven chronic inflammatory disease that is characterized by the formation of plaques at predilection sites. These predilection sites (side branches, curved segments, and bifurcations) have often been associated with disturbed shear stress profiles. However, in addition to shear stress, endothelial cells also experience artery wall strain that could contribute to atherosclerosis progression. Herein, we describe a method to accurately obtain these shear stress and strain profiles. We developed a fluid-structure interaction (FSI) framework for modelling arteries within a commercially available package (Abaqus, version 6.12) that included known prestresses (circumferential, axial and pressure associated). In addition, we co-registered 3D histology to a micro-CT-derived 3D reconstruction of an atherosclerotic carotid artery from a cholesterol-fed ApoE-/-mouse to include the spatial distribution of lipids within a subject-specific model. The FSI model also incorporated a nonlinear hyperelastic material model with regionally varying properties that distinguished between healthy vessel wall and plaque. FSI predicted a lower shear stress than CFD (--12%), but further decreases in plaque regions with softer properties (--24%) were dependent on the approach used to implement the prestresses in the artery wall. When implemented with our new hybrid approach (zero prestresses in regions of lipid deposition), there was significant heterogeneity in endothelial shear stress in the atherosclerotic artery due to variations in stiffness and, in turn, wall strain. In conclusion, when obtaining endothelial shear stress and strain in diseased arteries, a careful consideration of prestresses is necessary. This paper offers a way to implement them.

ELSEVIER SCI LTD2021

Chargement

Modulation of arginase pathway by hemodynamic forces

Fabienne Riche

It is well recognized that alterations on wall shear stress plays an important role on the development of atherosclerosis disease. It is known that oscillatory shear stress (OSS) flow pattern induces endothelial dysfunction via changes on nitric oxide (NO) pathway. NO is a potent vasodilator molecule and its availability can be evaluated by vasoreactivity organ chamber experiment. Arginase is an enzyme which is implicated in the signaling pathway of NO as it competes with endothelium nitric oxide synthase (eNOS) for the use of arginine. Increase in arginase expression and activity has been associated atherosclerosis, however the modulation of arginase by wall shear stress has never been studied before. This project consists of experimental work to better understand the implication of shear stress, NO and arginase expression in endothelial dysfunction of arteries. By using western blot and immunohistochemistry techniques we investigated the expression and localization of arginase in pig carotid arteries (PCA) perfused in an ex vivo arterial support system. While arginase I isoform was not present in PCA, arginase II was constitutively expressed. Its expression was augmented by exposure to high shear stress (HSS) flow and dependent of flow duration. OSS flow significantly increases the expression of arginase as compared to HSS. Inhibition of arginase in PCA perfused under OSS was not able to improve endothelial function neither NO availability. In a second part we characterize the geometry of rabbit carotid bifurcation and investigate if the receptor-mediated endothelial function and NO availability varies in this bifurcation. In the presence of NOS inhibitor, the contraction of the arteries in response to norepinephirne was higher. This difference is significant for segments which have the better endothelial dependant relaxation: the external carotid and the middle part of the common carotid.

2008

Chargement

, ,

Objective Plaque-prone areas are exposed to a particular hemodynamic environment characterized by a low mean shear stress value and a cyclic reversal flow. This mechanical environment, also termed oscillatory shear stress (OSS), induces the expression of several pro-atherogenic genes in the endothelial cells including the preproendothelin-1 (ppET-1) gene. The present paper investigates the molecular mechanisms of this induction. Methods and results Several deletional mutants of ppET-1 gene promoter were cloned upstream of a luciferase gene and transiently transfected in bovine arterial endothelial cells that were further exposed to plaque-prone hemodynamics. After 24 h of flow exposure, analysis of the transfected cells showed that a proximal promoter of 156 base pairs length retained OSS responsiveness. Mutation of an activator protein-1 (AP-1) binding site present in this minimal promoter completely abolished its activation by OSS. Consistently, electrophoresis mobility shift assay revealed a sustained activation of AP-1 transcription factor in endothelial cells exposed to OSS. In addition to the transcriptional activation, we demonstrated that OSS also induces a stabilization of ppET-1 mRNA through the 3′-untranslated region (3′-UTR) of this gene. Fluvastatin, a drug known to improve endothelial function, was shown to prevent OSS up-regulation of the ppET-1 gene expression. Under this flow condition, fluvastatin affects ppET-1 gene expression via inhibition of its promoter activity without affecting ppET-1 mRNA stability. Conclusions The present study demonstrate that plaque-prone hemodynamic induces ppET-1 gene expression by both transcriptional and post-transcriptional mechanisms via an activation of AP-1 transcriptional factor and stabilization of mRNA. The transcriptional up-regulation of ppET-1 was shown to be fluvastatin sensitive.

2008

Chargement